About Cardinor
Cardinor is a company based in Oslo (Norway) founded in 2015.. Cardinor has raised $921.84 thousand across 5 funding rounds from investors including European Union, IIG PLC and EIC Fund. The company has 2 employees as of December 31, 2019. Cardinor offers products and services including Secretoneurin ELISA Assay. Cardinor operates in a competitive market with competitors including Topera, CoreMap, Wearlinq, Smartheart and Bionet, among others.
- Headquarter Oslo, Norway
- Employees 2 as on 31 Dec, 2019
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Cardinor As
-
Annual Revenue
$359.64 K (USD)8as on Dec 31, 2021
-
Net Profit
$592.42 K (USD)598as on Dec 31, 2021
-
EBITDA
$592.63 K (USD)598as on Dec 31, 2021
-
Total Equity Funding
$921.84 K (USD)
in 5 rounds
-
Latest Funding Round
$171.84 K (USD), Seed
Mar 31, 2021
-
Investors
European Union
& 2 more
-
Employee Count
2
as on Dec 31, 2019
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cardinor
Cardinor offers a comprehensive portfolio of products and services, including Secretoneurin ELISA Assay. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Assay for measuring secretoneurin in heart failure patients
Funding Insights of Cardinor
Cardinor has successfully raised a total of $921.84K across 5 strategic funding rounds. The most recent funding activity was a Seed round of $171.84 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Seed — $171,842
-
First Round
First Round
(10 Nov 2015)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Seed - Cardinor | Valuation | IIG |
|
| Feb, 2020 | Amount | Grant - Cardinor | Valuation |
investors |
|
| Dec, 2019 | Amount | Grant - Cardinor | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cardinor
Cardinor has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, IIG PLC and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed by IIG toward life sciences startups.
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cardinor
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cardinor
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cardinor Comparisons
Competitors of Cardinor
Cardinor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Topera, CoreMap, Wearlinq, Smartheart and Bionet, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Catheter-based electrophysiology mapping for atrial fibrillation treatment is offered.
|
|
| domain | founded_year | HQ Location |
Atrial fibrillation detection platform is provided for heart disorder management.
|
|
| domain | founded_year | HQ Location |
A wearable ECG device is provided for heart disorder detection.
|
|
| domain | founded_year | HQ Location |
Portable EKG device for home-based cardiac monitoring and early detection of issues.
|
|
| domain | founded_year | HQ Location |
Cord blood banking service provider along with services on genetic testing
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cardinor
Frequently Asked Questions about Cardinor
When was Cardinor founded?
Cardinor was founded in 2015.
Where is Cardinor located?
Cardinor is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.
Is Cardinor a funded company?
Cardinor is a funded company, having raised a total of $921.84K across 5 funding rounds to date. The company's 1st funding round was a Grant of $133.27K, raised on Nov 10, 2015.
How many employees does Cardinor have?
As of Dec 31, 2019, the latest employee count at Cardinor is 2.
What is the annual revenue of Cardinor?
Annual revenue of Cardinor is $359.64K as on Dec 31, 2021.
What does Cardinor do?
Cardinor was founded in 2015 in Oslo, Norway, as a provider of biomarker-based assays targeting cardiovascular diseases. The assays utilize the neuropeptide secretoneurin, linked to cardiomyocyte calcium handling, to support identification of therapeutic strategies for heart disease patients. Operations focus on diagnostic applications, with the initial emphasis placed on arrhythmia testing within the biotechnology sector.
Who are the top competitors of Cardinor?
What products or services does Cardinor offer?
Cardinor offers Secretoneurin ELISA Assay.
Who are Cardinor's investors?
Cardinor has 3 investors. Key investors include European Union, IIG PLC, and EIC Fund.